BW813U

Overview

BW813U is a blood-brain barrier-permeable choline acetyltransferase ( ChAT ) inhibitor. BW813U reduces acetylcholine secretion, decreases cancer cell viability, and slows tumor growth rate. BW813U alters reference memory and causes working memory dysfunction. BW813U shows a synergistic effect with age factors in memory deficits of rats. BW813U can be used in studies related to Alzheimer's disease and lung cancer .

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Lung Cancer | Products > Disease Areas > Alzheimer's Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Acyltransferase

Product Information

• Catalog No.: HY-183572
• CAS No.: 774142-74-4
• Molecular Formula: C15H18ClNO
• Molecular Weight: 263.76
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source